Your browser doesn't support javascript.
loading
Histologically Overt Stromal Response and the Risk of Progression after Radical Prostatectomy for Prostate Cancer.
Sayan, Mutlay; Tuac, Yetkin; Kucukcolak, Samet; Rowan, Mary D; Pratt, Grace K; Aktan, Cagdas; Tjio, Elza; Akbulut, Dilara; Moningi, Shalini; Leeman, Jonathan E; Orio, Peter F; Nguyen, Paul L; D'Amico, Anthony V; Akgul, Mahmut.
Affiliation
  • Sayan M; Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Tuac Y; Department of Statistics, Ankara University, 06100 Ankara, Türkiye.
  • Kucukcolak S; Department of Pathology and Laboratory Medicine, Rutgers University, New Brunswick, NJ 07102, USA.
  • Rowan MD; Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Pratt GK; Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Aktan C; Department of Medical Biology, Faculty of Medicine, Bandirma Onyedi Eylul University, 10250 Balikesir, Türkiye.
  • Tjio E; Histopathology Department, Harrogate District Hospital, Harrogate HG2 7SX, UK.
  • Akbulut D; Laboratory of Pathology, Center for Cancer Research, National Institutes of Health, Bethesda, MD 20892, USA.
  • Moningi S; Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Leeman JE; Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Orio PF; Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Nguyen PL; Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • D'Amico AV; Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Akgul M; Department of Pathology and Laboratory Medicine, Albany Medical Center, Albany, NY 12208, USA.
Cancers (Basel) ; 16(10)2024 May 14.
Article de En | MEDLINE | ID: mdl-38791950
ABSTRACT

PURPOSE:

Given the variable clinical course of prostate cancer and the limitations of current prognostic factors, this study was conducted to investigate the impact of a histologically overt stromal response (HOST-response) to prostate cancer on clinical outcomes after radical prostatectomy.

METHODS:

This retrospective analysis utilized The Cancer Genome Atlas (TCGA) to evaluate data from individuals with a confirmed diagnosis of prostate cancer who underwent radical prostatectomy and had available pathology slides. These slides were assessed for the presence of a HOST-response, similar to desmoplasia. The primary endpoint was progression-free survival (PFS). A multivariable competing risk regression analysis was used to assess whether a significant association existed between HOST-response and PFS, adjusting for known prostate cancer prognostic factors.

RESULTS:

Among the 348 patients analyzed, 166 (47.70%) demonstrated a HOST-response. After a median follow-up of 37.87 months (IQR 21.20, 65.50), the presence of a HOST-response was significantly associated with a shorter PFS (SDHR, 2.10; 95% CI, 1.26 to 3.50; p = 0.004), after adjusting for covariates.

CONCLUSIONS:

HOST-response in prostate cancer patients treated with radical prostatectomy is significantly associated with reduced PFS, suggesting a potential benefit from adjuvant therapy and highlighting the need for further investigation in a prospective randomized clinical trial.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cancers (Basel) Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cancers (Basel) Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique